Table 2: Frequency of genotypes among South African and Senegalese prostate cancer cases and controls.

South Africa Senegal
GenotypesWhite MixedBlackCombinedSenegalese
GenesControls
( 4)
Cases
( )
Controls ( )Cases
( )
Controls ( )Cases
( )
Controls ( )Cases
( )
Controls ( )Cases
( )

CYP3A4 (rs2740574)
 AA122
(91.0%)
84
(70.0%)
117 (70.1%)82 (39.6%)2
(10.0%)
9
(36.0%)
241 (75.1%)175 (49.7%)21
(7.5%)
6
(7.1%)
 AG12
(9.0%)
34 (28.3%)49 (29.3%)111 (53.6%)15 (75.0%)16 (64.0%)76 (23.7%)161 (45.7%)91 (32.3%)40 (47.6%)
 GG0
(0%)
2
(1.7%)
1
(0.6%)
14
(6.8%)
3
(15.0%)
0
(0%)
4
(1.2%)
16
(4.6%)
170 (60.3%)38 (45.2%)

CYP3A5 (rs776746)
 GG113 (84.3%)95 (79.2%)58 (34.7%)58 (28.0%)1
(5.0%)
1
(4.0%)
172 (53.6%)154 (43.8%)14
(5.3%)
4
(5.1%)
 AG18 (13.4%)22 (18.3%)72 (43.1%)106 (51.2%)5
(25.0%)
5
(20.0%)
95 (29.6%)133 (37.8%)66 (25.1%)20 (25.3%)
 AA 3
(2.3%)
3
(2.5%)
37 (22.2%)43 (20.8%)14 (70.0%)19 (76.0%)54 (16.8%)65 (18.4%)183 (69.6%)55 (69.6%)

SRD5A2 V89L (rs523349)
 GG56 (41.8%)61 (50.8%)96 (57.5%)131 (63.3%)5
(25.0%)
16 (64.0%)157 (48.9%)208 (59.1%)26 (12.2%)10 (14.1%)
 CG70 (52.2%)51 (42.5%)65 (38.9%)71 (34.3%)7
(35.0%)
7
(28.0%)
142 (44.2%)129 (36.6%)61 (28.5%)10 (14.1%)
 CC 8
(6.0%)
8
(6.7%)
6
(3.6%)
5
(2.4%)
8
(40.0%)
2
(8.0%)
22
(6.9%)
15
(4.3%)
127 (59.4%)51 (71.8%)

SRD5A2 A49T (rs9282858)
 GG107 (79.8%)90 (75.0%)127 (76.0%)120 (58.0%)10 (50.0%)17 (68.0%)244 (76.0%)227 (64.5%)278 (100.0%)75 (100.0%)
 GA27 (20.2%)30 (25.0%)40 (24.0%)87 (42.0%)10 (50.0%)8
(32.0%)
77 (24.0%)125 (35.5%)0
(0%)
0
(0.0%)

, for each polymorphism when comparing across each of the respective population groups for cases or for controls.
Some participants had missing genotype data. The numbers and percentages shown are for the available information.